HDAC inhibitors have shown robust neuroprotection on cerebral ischemia-induced brain injury, which may be complex involving multiple mechanisms, such as the activated microglia-mediated inhibition of cerebral inflammation induced by ischemia (Kim et al., 2007). Here, HDAC9 is linked to Cerebral ischemia.